A Cyclometalated Ir-III Complex Conjugated to a Coumarin Derivative Is a Potent Photodynamic Agent against Prostate Differentiated and Tumorigenic Cancer Stem Cells

0542792 - BFÚ 2022 RIV DE eng J - Článek v odborném periodiku
Novohradský, Vojtěch - Marková, Lenka - Kostrhunová, Hana - Kašpárková, Jana - Ruiz, J. - Marchan, V. - Brabec, Viktor
A Cyclometalated Ir-III Complex Conjugated to a Coumarin Derivative Is a Potent Photodynamic Agent against Prostate Differentiated and Tumorigenic Cancer Stem Cells.
Chemistry - A European Journal. Roč. 27, č. 33 (2021), s. 8547-8556. ISSN 0947-6539. E-ISSN 1521-3765
Grant CEP: GA ČR(CZ) GA21-27514S
Institucionální podpora: RVO:68081707
Klíčová slova: calcium signals * apoptosis * antitumor agents * apoptosis * cancer stem cells
Obor OECD: Physical chemistry
Impakt faktor: 5.020, rok: 2021
Způsob publikování: Open access
https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/chem.202100568

A cyclometalated Ir-III complex conjugated to a far-red-emitting coumarin, Ir-III-COUPY (3), was recently shown as a very promising photosensitizer suitable for photodynamic therapy of cancer. Therefore, the primary goal of this work was to deepen knowledge on the mechanism of its photoactivated antitumor action so that this information could be used to propose a new class of compounds as drug candidates for curing very hardly treatable human tumors, such as androgen resistant prostatic tumors of metastatic origin. Conventional anticancer chemotherapies exhibit several disadvantages, such as limited efficiency to target cancer stem cells (CSCs), which are considered the main reason for chemotherapy resistance, relapse, and metastasis. Herein, we show, using DU145 tumor cells, taken as the model of hormone-refractory and aggressive prostate cancer cells resistant to conventional antineoplastic drugs, that the photoactivated conjugate 3 very efficiently eliminates both prostate bulk (differentiated) and prostate hardly treatable CSCs simultaneously and with a similar efficiency. Notably, the very low toxicity of Ir-III-COUPY conjugate in the prostate DU145 cells in the dark and its pronounced selectivity for tumor cells compared with noncancerous cells could result in low side effects and reduced damage of healthy cells during the photoactivated therapy by this agent. Moreover, the experiments performed with the 3D spheroids formed from DU145 CSCs showed that conjugate 3 can penetrate the inner layers of tumor spheres, which might markedly increase its therapeutic effect. Also interestingly, this conjugate induces apoptotic cell death in prostate cancer DU145 cells associated with calcium signaling flux in these cells and autophagy. To the best of our knowledge, this is the first study demonstrating that a photoactivatable metal-based compound is an efficient agent capable of killing even hardly treatable CSCs.
Trvalý link: http://hdl.handle.net/11104/0320140